Abstract

Synthetic drugs are gradually changing the landscape of drug addiction in Europe, according to the annual report of the European Monitoring Center for Drugs and Drug Addiction (EMCDDA), which reports a reduction in cannabis and heroin use but an increasing prevalence of synthetic psychotropic substances, especially among young people. A synthetic drug appears every week in Europe, when the years 2000-2005 came out five a year. According to a UN report, synthetic drugs, "legal psychotropic drugs" or "psychotropic herbs", are an increasingly important public health challenge in many countries. The number of cases from the use of such substances increases significantly, while several deaths are reported after the use of these substances. The purpose of this study is to show cognitive deficits in a young female patient with a history of GHB use. The case of a 29-year-old woman who was treated at a university psychiatric clinic in Thessaloniki / Greece is presented.